Eriocitrin Attenuates Diabetic Cardiomyopathy by Regulating Copper Homeostasis and Cuproptosis-Associated Pathways via SIRT7/YAP/ATP7A Signalling.

Chen L, Mao S, Yu Y, Zhang D, Fan Z

Open source

DOI
10.1111/bcpt.70301
Published
2026 Oct
Container
Basic & clinical pharmacology & toxicology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bcpt.70301,
  title = {Eriocitrin Attenuates Diabetic Cardiomyopathy by Regulating Copper Homeostasis and Cuproptosis-Associated Pathways via SIRT7/YAP/ATP7A Signalling.},
  author = {Chen L and Mao S and Yu Y and Zhang D and Fan Z},
  year = {2026},
  journal = {Basic \& clinical pharmacology \& toxicology},
  doi = {10.1111/bcpt.70301},
  url = {https://doi.org/10.1111/bcpt.70301}
}

RIS

TY  - JOUR
TI  - Eriocitrin Attenuates Diabetic Cardiomyopathy by Regulating Copper Homeostasis and Cuproptosis-Associated Pathways via SIRT7/YAP/ATP7A Signalling.
AU  - Chen L
AU  - Mao S
AU  - Yu Y
AU  - Zhang D
AU  - Fan Z
PY  - 2026
JO  - Basic & clinical pharmacology & toxicology
DO  - 10.1111/bcpt.70301
UR  - https://doi.org/10.1111/bcpt.70301
ER  - 

APA

L, C., S, M., Y, Y., D, Z., & Z, F. (2026). Eriocitrin Attenuates Diabetic Cardiomyopathy by Regulating Copper Homeostasis and Cuproptosis-Associated Pathways via SIRT7/YAP/ATP7A Signalling.. Basic & clinical pharmacology & toxicology. https://doi.org/10.1111/bcpt.70301

Source records